Corrigendum to: A Comprehensive Investigation: Developing the Pharmaceutical Industry through Artificial Intelligence
Related Experiment Videos
Deepak Jain1, Phool Chandra2, Zeeshan Ali3
1Department of Pharmaceutics, School of Pharmacy-AVIPS, Shobit University, Gangoh, Uttar Pradesh, 247341, India.
Abstract:
Following publication of the article entitled "A Comprehensive Investigation: Developing the Pharmaceutical Industry through Artificial Intelligence" [1], a phrase was identified that was unclear or inconsistent with the established scientific terminology. To ensure the accuracy and clarity of the published record, this expression has been corrected using appropriate terminology that more accurately conveys the intended scientific meaning. The correction is limited to the wording and terminology of the affected passage and does not alter the data, results, scientific interpretations, or conclusions of the article. The specific corrections are provided below: Section 1.1, Paragraph 1 Original text: Artificial Intelligence refreshen drug discovery by using deep knowledge and logical language processing which can easily understand and analyze broad quantities of bioscience information. Corrected text: Artificial Intelligence refreshen drug discovery by using deep knowledge and natural language processing (NLP) which can easily understand and analyze broad quantities of bioscience information. The original article has been updated accordingly. This corrigendum is published to ensure transparency and accuracy of the scholarly record. The corrected version of the article is available online at: https://www.eurekaselect.com/article/142839 The authors regret the error and apologise for any inconvenience they may have caused.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Discovery: Overview
FDA Approved Drugs: Changes to Approved Drugs
Biopharmaceutical Factors Influencing Drug Product Design: Overview